Zambon Company S.p.A. - Product Pipeline Review - 2015

  • ID: 3608125
  • Company Profile
  • 31 pages
  • Global Markets Direct
1 of 4
Zambon Company S.p.A. - Product Pipeline Review - 2015

Summary

The report ‘Zambon Company S.p.A. - Product Pipeline Review - 2015’, provides an overview of the Zambon Company S.p.A.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Zambon Company S.p.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Zambon Company S.p.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Zambon Company S.p.A.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Zambon Company S.p.A.’s pipeline products

Reasons to buy

- Evaluate Zambon Company S.p.A.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Zambon Company S.p.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Zambon Company S.p.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Zambon Company S.p.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zambon Company S.p.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Zambon Company S.p.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Zambon Company S.p.A. Snapshot

Zambon Company S.p.A. Overview

Key Information

Key Facts

Zambon Company S.p.A. - Research and Development Overview

Key Therapeutic Areas

Zambon Company S.p.A. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Zambon Company S.p.A. - Pipeline Products Glance

Zambon Company S.p.A. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Zambon Company S.p.A. - Unknown Stage Pipeline Products

Unknown Products/Combination Treatment Modalities

Zambon Company S.p.A. - Drug Profiles

ZP-040

Product Description

Mechanism of Action

R&D Progress

ZP-046

Product Description

Mechanism of Action

R&D Progress

ZP-049

Product Description

Mechanism of Action

R&D Progress

ZP-053

Product Description

Mechanism of Action

R&D Progress

ZP-003

Product Description

Mechanism of Action

R&D Progress

ZP-008

Product Description

Mechanism of Action

R&D Progress

ZP-044

Product Description

Mechanism of Action

R&D Progress

ZP-051

Product Description

Mechanism of Action

R&D Progress

Zambon Company S.p.A. - Pipeline Analysis

Zambon Company S.p.A. - Pipeline Products by Route of Administration

Zambon Company S.p.A. - Pipeline Products by Molecule Type

Zambon Company S.p.A. - Dormant Projects

Zambon Company S.p.A. - Company Statement

Zambon Company S.p.A. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Zambon Company S.p.A., Key Information

Zambon Company S.p.A., Key Facts

Zambon Company S.p.A. - Pipeline by Indication, 2015

Zambon Company S.p.A. - Pipeline by Stage of Development, 2015

Zambon Company S.p.A. - Monotherapy Products in Pipeline, 2015

Zambon Company S.p.A. - Partnered Products in Pipeline, 2015

Zambon Company S.p.A. - Partnered Products/ Combination Treatment Modalities, 2015

Zambon Company S.p.A. - Preclinical, 2015

Zambon Company S.p.A. - Unknown, 2015

Zambon Company S.p.A. - Pipeline by Route of Administration, 2015

Zambon Company S.p.A. - Pipeline by Molecule Type, 2015

Zambon Company S.p.A. - Dormant Developmental Projects,2015

Zambon Company S.p.A., Other Locations

Zambon Company S.p.A., Subsidiaries

List of Figures

Zambon Company S.p.A. - Pipeline by Top 10 Indication, 2015

Zambon Company S.p.A. - Pipeline by Stage of Development, 2015

Zambon Company S.p.A. - Monotherapy Products in Pipeline, 2015

Zambon Company S.p.A. - Partnered Products in Pipeline, 2015

Zambon Company S.p.A. - Pipeline by Top 10 Molecule Type, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll